The American College of Radiology criticized a study by the Agency for Healthcare Research and Quality that found current noninvasive imaging cannot replace biopsy to exclude or confirm breast cancer.
The American College of Radiology criticized a study by the Agency for Healthcare Research and Quality that found current noninvasive imaging cannot replace biopsy to exclude or confirm breast cancer.
The report, Effectiveness of noninvasive diagnostic tests for breast abnormalities, stated that the accuracy of scintimammography, PET, ultrasound, and MRI is suboptimal compared with biopsy.
Officials in the ACR said that breast imagers are well acquainted with the protocol regarding a suspicious mammographic finding, which generally calls for biopsy. The college also expressed concern that the report would mislead women into foregoing additional imaging after an inconclusive screening mammogram.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.